MedTrace Logo

Characterization of Macroprolactinemia

NCT00436111 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2007-02-16

No results posted yet for this study

Summary

The purpose of this study is to clarify the nature of macroprolactin which has recently been highlighted because of the high prevalence and a diagnostic pitfall of hyperprolactinemia. The results of this study are beneficial for the patients to whom unnecessary medications and unnecessary radiological examinations have been performed.

We used the remained serum samples taken for routine prolactin determination during the past several years. Since the blood was basically taken to examine the causes of hyperprolactinemia and only remained serum samples were used for this study, the Ethics Committee of Kobe City General Hospital judged that it was not required to obtain approval number.

Conditions

  • Hyperprolactinemia

Sponsors & Collaborators

  • Kansai Medical University

    lead OTHER

Principal Investigators

  • Naoki Hattori, M.D., Ph.D. · Department of Pharmacology, Kansai Medical University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Completion
2006-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00436111 on ClinicalTrials.gov